Tokyo, Japan

Mitsunobu Yoshii


Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2000-2002

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mitsunobu Yoshii: Innovator in Mitochondrial Research

Introduction

Mitsunobu Yoshii is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of mitochondrial research, holding a total of 3 patents. His work focuses on developing therapeutic methods for diseases related to mitochondrial dysfunction.

Latest Patents

Yoshii's latest patents include a mitochondrial membrane stabilizer, which offers a prophylactic and therapeutic method for treating diseases caused by mitochondrial functional abnormalities. This innovative approach involves administering a medicament that stabilizes mitochondrial membranes by suppressing or eliminating depolarization caused by elevated intracellular calcium ion concentrations. The diseases targeted by this invention may include ischemic, toxic, or degenerative diseases. Another notable patent addresses remedies or preventives for intractable epilepsy, featuring a therapeutic agent that comprises a compound with specific structural characteristics.

Career Highlights

Throughout his career, Mitsunobu Yoshii has worked with notable companies, including Daiichi Pharmaceutical Co., Ltd. and other pharmaceutical organizations. His expertise in mitochondrial research has positioned him as a key figure in the development of novel therapeutic strategies.

Collaborations

Yoshii has collaborated with esteemed colleagues such as Tatsuya Tanaka and Akira Takazawa, contributing to advancements in the field of pharmaceutical research.

Conclusion

Mitsunobu Yoshii's innovative work in mitochondrial research and his contributions to therapeutic methods highlight his importance as an inventor. His patents reflect a commitment to addressing critical health challenges related to mitochondrial dysfunction.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…